Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
3,535
Price
$50.03
Total Value
$176,851.10
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Sep 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Sep 21, 2026 |
| Shares Sold | 3,535 |
| Price per Share | $50.03 |
| Total Value | $176,851.10 |
| Shares Owned After | 40,483 |
| Derivative | No |
| Accession Number | 0001882764-26-000008 |
| Document | View SEC Filing |